======= NFYB ======= == Gene Information == * **Official Symbol**: NFYB * **Official Name**: nuclear transcription factor Y subunit beta * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4801|4801]] * **UniProt**: [[https://www.uniprot.org/uniprot/P25208|P25208]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NFYB&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NFYB|Open PubMed]] * **OMIM**: [[https://omim.org/entry/189904|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the sequence-specific heterotrimeric transcription factor (NF-Y) which specifically recognizes a 5'- CCAAT-3' box motif found in the promoters of its target genes. NF- Y can function as both an activator and a repressor, depending on its interacting cofactors. |Histone| |CBFD NFYB HMF| |CCAAT-binding factor complex| |repressing transcription factor binding| |regulation of sterol biosynthetic process| |regulation of cholesterol biosynthetic process| |protein-DNA complex| |regulation of cholesterol metabolic process| |RNA polymerase II transcription factor complex| |regulation of alcohol biosynthetic process| |regulation of steroid biosynthetic process| |cellular response to leukemia inhibitory factor| |response to leukemia inhibitory factor| |RNA polymerase II distal enhancer sequence-specific DNA binding| |regulation of steroid metabolic process| |regulation of lipid biosynthetic process| |transcription regulatory region DNA binding| |protein-containing complex binding| |regulation of lipid metabolic process| |regulation of small molecule metabolic process| |protein heterodimerization activity| |DNA-binding transcription factor activity| |cellular response to cytokine stimulus| |response to cytokine| |DNA binding| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|1.7| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.75| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|1.87| |[[:results:exp27|Pimelic-diphenylamide-106 0.5μM R00 exp27]]|2.02| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|2.47| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.58| ^Gene^Correlation^ |[[:human genes:n:nfyc|NFYC]]|0.452| |[[:human genes:c:cox8a|COX8A]]|0.412| Global Fraction of Cell Lines Where Essential: 129/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|5/28| |blood|6/28| |bone|6/25| |breast|8/33| |central nervous system|12/56| |cervix|0/4| |colorectal|1/17| |esophagus|1/13| |fibroblast|0/1| |gastric|1/15| |kidney|2/21| |liver|3/20| |lung|15/75| |lymphocyte|4/14| |ovary|6/26| |pancreas|2/24| |peripheral nervous system|3/16| |plasma cell|3/15| |prostate|0/1| |skin|7/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|3/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1548 * **Expression level (log2 read counts)**: 5.17 {{:chemogenomics:nalm6 dist.png?nolink |}}